Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression
Authors
Keywords
-
Journal
Nature Communications
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-11-22
DOI
10.1038/s41467-017-01651-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor-penetrating peptide enhances transcytosis of silicasome-based chemotherapy for pancreatic cancer
- (2017) Xiangsheng Liu et al. JOURNAL OF CLINICAL INVESTIGATION
- Irinotecan Delivery by Lipid-Coated Mesoporous Silica Nanoparticles Shows Improved Efficacy and Safety over Liposomes for Pancreatic Cancer
- (2016) Xiangsheng Liu et al. ACS Nano
- Inducing enhanced immunogenic cell death with nanocarrier-based drug delivery systems for pancreatic cancer therapy
- (2016) Xiao Zhao et al. BIOMATERIALS
- The safety and efficacy of Onivyde (irinotecan liposome injection) for the treatment of metastatic pancreatic cancer following gemcitabine-based therapy
- (2016) Frank C. Passero et al. Expert Review of Anticancer Therapy
- Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy
- (2016) Christina Pfirschke et al. IMMUNITY
- [18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity
- (2016) Woosuk Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A phase I study of indoximod in patients with advanced malignancies
- (2016) Hatem H. Soliman et al. Oncotarget
- Use of a Lipid-Coated Mesoporous Silica Nanoparticle Platform for Synergistic Gemcitabine and Paclitaxel Delivery to Human Pancreatic Cancer in Mice
- (2015) Huan Meng et al. ACS Nano
- An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy
- (2015) R. Tavare et al. CANCER RESEARCH
- Immuno-PET of Murine T Cell Reconstitution Postadoptive Stem Cell Transplantation Using Anti-CD4 and Anti-CD8 Cys-Diabodies
- (2015) R. Tavare et al. JOURNAL OF NUCLEAR MEDICINE
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- (2015) Stefani Spranger et al. NATURE
- A paclitaxel-loaded recombinant polypeptide nanoparticle outperforms Abraxane in multiple murine cancer models
- (2015) Jayanta Bhattacharyya et al. Nature Communications
- Pancreatic cancer: Update on immunotherapies and algenpantucel-L
- (2015) Kinsey A. McCormick et al. Human Vaccines & Immunotherapeutics
- Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR
- (2015) Ulrike M. Litzenburger et al. Oncotarget
- A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumors
- (2015) Hatem H. Soliman et al. Oncotarget
- Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML
- (2014) J. E. Lancet et al. BLOOD
- Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity
- (2014) Miranda L. Broz et al. CANCER CELL
- Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer
- (2014) George C. Prendergast et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)-Specific MHC Class I/II-Restricted Epitopes for Pancreatic Cancer
- (2014) S. Koido et al. CLINICAL CANCER RESEARCH
- Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug efflux
- (2014) Richard E Lee et al. NATURE MEDICINE
- Trial watch: IDO inhibitors in cancer therapy
- (2014) Erika Vacchelli et al. OncoImmunology
- Codelivery of an Optimal Drug/siRNA Combination Using Mesoporous Silica Nanoparticles To Overcome Drug Resistance in Breast Cancer in Vitro and in Vivo
- (2013) Huan Meng et al. ACS Nano
- Two-Wave Nanotherapy To Target the Stroma and Optimize Gemcitabine Delivery To a Human Pancreatic Cancer Model in Mice
- (2013) Huan Meng et al. ACS Nano
- Hyaluronan, fluid pressure and stromal resistance in pancreas cancer
- (2013) P P Provenzano et al. BRITISH JOURNAL OF CANCER
- Novel Pancreatic Cancer Cell Lines Derived from Genetically Engineered Mouse Models of Spontaneous Pancreatic Adenocarcinoma: Applications in Diagnosis and Therapy
- (2013) María P. Torres et al. PLoS One
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Mesoporous silica nanoparticles in biomedical applications
- (2012) Zongxi Li et al. CHEMICAL SOCIETY REVIEWS
- Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile
- (2012) J. Hrkach et al. Science Translational Medicine
- nab -Paclitaxel Potentiates Gemcitabine Activity by Reducing Cytidine Deaminase Levels in a Mouse Model of Pancreatic Cancer
- (2012) Kristopher K. Frese et al. Cancer Discovery
- IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan
- (2012) Richard Metz et al. OncoImmunology
- Use of Size and a Copolymer Design Feature To Improve the Biodistribution and the Enhanced Permeability and Retention Effect of Doxorubicin-Loaded Mesoporous Silica Nanoparticles in a Murine Xenograft Tumor Model
- (2011) Huan Meng et al. ACS Nano
- Human Tumor Cells Killed by Anthracyclines Induce a Tumor-Specific Immune Response
- (2011) J. Fucikova et al. CANCER RESEARCH
- Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
- (2011) M. Michaud et al. SCIENCE
- CD91-dependent programming of T-helper cell responses following heat shock protein immunization
- (2011) Sudesh Pawaria et al. Nature Communications
- Improved Clinical Outcome in Indolent B-Cell Lymphoma Patients Vaccinated with Autologous Tumor Cells Experiencing Immunogenic Death
- (2010) R. Zappasodi et al. CANCER RESEARCH
- Development of an Orthotopic Model of Invasive Pancreatic Cancer in an Immunocompetent Murine Host
- (2010) W. W. Tseng et al. CLINICAL CANCER RESEARCH
- Polyethyleneimine Coating Enhances the Cellular Uptake of Mesoporous Silica Nanoparticles and Allows Safe Delivery of siRNA and DNA Constructs
- (2009) Tian Xia et al. ACS Nano
- [186Re]Liposomal doxorubicin (Doxil): in vitro stability, pharmacokinetics, imaging and biodistribution in a head and neck squamous cell carcinoma xenograft model
- (2009) Anuradha Soundararajan et al. NUCLEAR MEDICINE AND BIOLOGY
- Immunogenic death of colon cancer cells treated with oxaliplatin
- (2009) A Tesniere et al. ONCOGENE
- Vaccinia Peptides Eluted from HLA-DR1 Isolated from Virus-Infected Cells Are Recognized by CD4+T Cells from a Vaccinated Donor
- (2008) Iwona Strug et al. JOURNAL OF PROTEOME RESEARCH
- Molecular imaging of lymphoid organs and immune activation by positron emission tomography with a new [18F]-labeled 2′-deoxycytidine analog
- (2008) Caius G Radu et al. NATURE MEDICINE
- Toxicology and pharmacokinetics of 1-methyl-d-tryptophan: Absence of toxicity due to saturating absorption
- (2007) Lee Jia et al. FOOD AND CHEMICAL TOXICOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started